These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 27746396)

  • 1. Procalcitonin to guide taking blood cultures in the intensive care unit; a cluster-randomized controlled trial.
    van der Geest PJ; Mohseni M; Nieboer D; Duran S; Groeneveld ABJ
    Clin Microbiol Infect; 2017 Feb; 23(2):86-91. PubMed ID: 27746396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intensive care infection score - a novel marker for the prediction of infection and its severity.
    van der Geest PJ; Mohseni M; Linssen J; Duran S; de Jonge R; Groeneveld AB
    Crit Care; 2016 Jul; 20(1):180. PubMed ID: 27384242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
    de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
    Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.
    Bouadma L; Luyt CE; Tubach F; Cracco C; Alvarez A; Schwebel C; Schortgen F; Lasocki S; Veber B; Dehoux M; Bernard M; Pasquet B; Régnier B; Brun-Buisson C; Chastre J; Wolff M;
    Lancet; 2010 Feb; 375(9713):463-74. PubMed ID: 20097417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Procalcitonin And Survival Study (PASS) - a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients.
    Jensen JU; Lundgren B; Hein L; Mohr T; Petersen PL; Andersen LH; Lauritsen AO; Hougaard S; Mantoni T; Bømler B; Thornberg KJ; Thormar K; Løken J; Steensen M; Carl P; Petersen JA; Tousi H; Søe-Jensen P; Bestle M; Hestad S; Andersen MH; Fjeldborg P; Larsen KM; Rossau C; Thomsen CB; Ostergaard C; Kjaer J; Grarup J; Lundgren JD
    BMC Infect Dis; 2008 Jul; 8():91. PubMed ID: 18620598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock: A Randomized Clinical Trial.
    Bloos F; Trips E; Nierhaus A; Briegel J; Heyland DK; Jaschinski U; Moerer O; Weyland A; Marx G; Gründling M; Kluge S; Kaufmann I; Ott K; Quintel M; Jelschen F; Meybohm P; Rademacher S; Meier-Hellmann A; Utzolino S; Kaisers UX; Putensen C; Elke G; Ragaller M; Gerlach H; Ludewig K; Kiehntopf M; Bogatsch H; Engel C; Brunkhorst FM; Loeffler M; Reinhart K;
    JAMA Intern Med; 2016 Sep; 176(9):1266-76. PubMed ID: 27428731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin increase in early identification of critically ill patients at high risk of mortality.
    Jensen JU; Heslet L; Jensen TH; Espersen K; Steffensen P; Tvede M
    Crit Care Med; 2006 Oct; 34(10):2596-602. PubMed ID: 16915118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delta Procalcitonin Is a Better Indicator of Infection Than Absolute Procalcitonin Values in Critically Ill Patients: A Prospective Observational Study.
    Trásy D; Tánczos K; Németh M; Hankovszky P; Lovas A; Mikor A; Hajdú E; Osztroluczki A; Fazakas J; Molnár Z
    J Immunol Res; 2016; 2016():3530752. PubMed ID: 27597981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial.
    Jensen JU; Hein L; Lundgren B; Bestle MH; Mohr TT; Andersen MH; Thornberg KJ; Løken J; Steensen M; Fox Z; Tousi H; Søe-Jensen P; Lauritsen AØ; Strange D; Petersen PL; Reiter N; Hestad S; Thormar K; Fjeldborg P; Larsen KM; Drenck NE; Ostergaard C; Kjær J; Grarup J; Lundgren JD;
    Crit Care Med; 2011 Sep; 39(9):2048-58. PubMed ID: 21572328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial.
    Shehabi Y; Sterba M; Garrett PM; Rachakonda KS; Stephens D; Harrigan P; Walker A; Bailey MJ; Johnson B; Millis D; Ding G; Peake S; Wong H; Thomas J; Smith K; Forbes L; Hardie M; Micallef S; Fraser JF; ;
    Am J Respir Crit Care Med; 2014 Nov; 190(10):1102-10. PubMed ID: 25295709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin-Guided Treatment on Duration of Antibiotic Therapy and Cost in Septic Patients (PRODA): a Multi-Center Randomized Controlled Trial.
    Jeon K; Suh JK; Jang EJ; Cho S; Ryu HG; Na S; Hong SB; Lee HJ; Kim JY; Lee SM
    J Korean Med Sci; 2019 Apr; 34(14):e110. PubMed ID: 30977312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): study protocol for a pilot randomized controlled trial.
    Daneman N; Rishu AH; Xiong W; Bagshaw SM; Cook DJ; Dodek P; Hall R; Kumar A; Lamontagne F; Lauzier F; Marshall JC; Martin CM; McIntyre L; Muscedere J; Reynolds S; Stelfox HT; Fowler RA;
    Trials; 2015 Apr; 16():173. PubMed ID: 25903783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients.
    Layios N; Lambermont B; Canivet JL; Morimont P; Preiser JC; Garweg C; Ledoux D; Frippiat F; Piret S; Giot JB; Wiesen P; Meuris C; Massion P; Leonard P; Nys M; Lancellotti P; Chapelle JP; Damas P
    Crit Care Med; 2012 Aug; 40(8):2304-9. PubMed ID: 22809906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin-guided antibiotic therapy duration in critically ill adults.
    Walker C
    AACN Adv Crit Care; 2015; 26(2):99-106. PubMed ID: 25898876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin (PCT) is useful in predicting the bacterial origin of an acute circulatory failure in critically ill patients.
    Cheval C; Timsit JF; Garrouste-Orgeas M; Assicot M; De Jonghe B; Misset B; Bohuon C; Carlet J
    Intensive Care Med; 2000 Mar; 26 Suppl 2():S153-8. PubMed ID: 18470711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome.
    Simon L; Saint-Louis P; Amre DK; Lacroix J; Gauvin F
    Pediatr Crit Care Med; 2008 Jul; 9(4):407-13. PubMed ID: 18496408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Old and new biomarkers for predicting high and low risk microbial infection in critically ill patients with new onset fever: a case for procalcitonin.
    Hoeboer SH; Alberts E; van den Hul I; Tacx AN; Debets-Ossenkopp YJ; Groeneveld AB
    J Infect; 2012 May; 64(5):484-93. PubMed ID: 22248983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal changes in procalcitonin in a heterogeneous group of critically ill patients.
    Reynolds SC; Shorr AF; Muscedere J; Jiang X; Heyland DK
    Crit Care Med; 2012 Oct; 40(10):2781-7. PubMed ID: 22824927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial.
    Schuetz P; Kutz A; Grolimund E; Haubitz S; Demann D; Vögeli A; Hitz F; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Marlowe RJ; Zimmerli W; Mueller B;
    Int J Cardiol; 2014 Aug; 175(3):464-72. PubMed ID: 25005339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin-guided antibiotic therapy in critically ill adults: a meta-analysis.
    Zhang T; Wang Y; Yang Q; Dong Y
    BMC Infect Dis; 2017 Jul; 17(1):514. PubMed ID: 28738787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.